Learn about early-onset Alzheimer's through real stories of hope and breakthrough treatments that are changing lives of patients diagnosed before age ...
A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...
When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...
Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...
Building on decades of the Company's Alzheimer's research, two differentiated investigational therapies aim to slow ...
The report forecasted that the Alzheimer's disease market in these countries to grow from $2.4 billion in 2023 to $19.3 ...
This groundbreaking finding, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggests that ...
Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...
A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...
Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.
While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...